Phase1 trial of Cetuximab/S-1 combination therapy for Advanced/Recurrent Colorectal Cancer
收藏NIAID Data Ecosystem2026-03-06 收录
官方服务：
资源简介：
Interventions: cetuximab S-1 combination therapy cetuximab : Weekly administration 400 mg/m2 for the 1st time (day1), 250mg/m2/week for the 2nd time or another (day8,15,..) S-1 : 60 or 80 mg/m2/2weeks/day1-14, 4weeks Primary outcome(s): To determine the recomend dose of cetuximab and S-1 combinaton therapy Study Design: Single arm Non-randomized
创建时间：
2010-03-15
